NOVEOS Specific IgE (sIgE) +5 more— 510(k) K260591

Substantially Equivalent

Hycor Biomedical

FDA 510(k) clearance K260591 for NOVEOS Specific IgE (sIgE) +5 more, Substantially Equivalent on 2026-07-21. Applicant: Hycor Biomedical. Device class: 2.

Summary

Hycor Biomedical's clearance covers NOVEOS Specific IgE (sIgE) and five capture reagents: F010 Sesame Seed, F020 Almond, F078 Bos d 8 Casein (Milk), F080 Lobster, and F422 Ara h 1 (Peanut). They're filed under DHB, radioallergosorbent (RAST) immunological test systems.

Class II, 21 CFR 866.5750. Immunology is both the classification panel and the review panel, and it was a Traditional 510(k).

Hycor filed from Garden Grove, California. Review took 148 calendar days (February 23 to July 21, 2026).

Clearance details

Device name as filed
NOVEOS Specific IgE (sIgE);Capture Reagent F010, Sesame Seed (Sesamum indicum);Capture Reagent F020, Almond (Amygdalus communis);Capture Reagent F078, Bos d 8 Casein, Milk; Capture Reagent F080, Lobster (Homarus gammarus);Capture Reagent F422, Ara h 1, Peanut
Applicant
Hycor Biomedical
Product code
Product code DHB
Device class
Class 2
Regulation
21 CFR 866.5750
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Garden Grove, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DHB

view all

More clearances from Hycor Biomedical

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.